Webb E, Tkalcevic J, Edwards S, Hocking D, Nisbet I
Research and Development Division, CSL Limited, Parkville, Victoria, Australia.
Biochem Biophys Res Commun. 1993 Jan 29;190(2):536-43. doi: 10.1006/bbrc.1993.1081.
Factor VIII is a complex, plasma glycoprotein involved in the process of blood coagulation. Production of the recombinant molecule has largely been confined to mammalian cell systems which have, in general, proven to be inefficient producers of factor VIII. The use of a baculovirus expression system may provide increased levels of this glycoprotein, although it is not certain that insect cell-derived factor VIII will be biologically active. The N-linked glycosylation patterns in insect cells, until recently thought to be less complex than in mammalian cells, may influence activity and/or secretory ability. To this end we engineered a B domain-deleted factor VIII cDNA sequence for expression in Spodoptera frugiperda cells. The construct retained the native signal sequence to allow secretion of recombinant protein into the culture medium. Initial studies revealed the production of secreted factor VIII, and this protein was shown to possess coagulation activity. The presence of N-linked oligosaccharide residues was demonstrated, the glycosylated molecule being of a similar size to that expressed in mammalian cells.
凝血因子 VIII 是一种参与血液凝固过程的复杂血浆糖蛋白。重组分子的生产主要局限于哺乳动物细胞系统,总体而言,这些系统已被证明是凝血因子 VIII 的低效生产者。杆状病毒表达系统的使用可能会提高这种糖蛋白的产量,尽管尚不确定昆虫细胞衍生的凝血因子 VIII 是否具有生物活性。直到最近,人们还认为昆虫细胞中的 N 连接糖基化模式比哺乳动物细胞中的简单,它可能会影响活性和/或分泌能力。为此,我们设计了一个缺失 B 结构域的凝血因子 VIII cDNA 序列,用于在草地贪夜蛾细胞中表达。该构建体保留了天然信号序列,以便将重组蛋白分泌到培养基中。初步研究揭示了分泌型凝血因子 VIII 的产生,并且该蛋白显示具有凝血活性。已证实存在 N 连接寡糖残基,糖基化分子的大小与在哺乳动物细胞中表达的分子相似。